Temaz and Pleurisy - a phase IV clinical study of FDA data

Summary:

Pleurisy is reported as a side effect among people who take Temaz (temazepam), especially for people who are female, 60+ old, also take Alprazolam, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Pleurisy when taking Temaz. It is created by eHealthMe based on reports of 40,916 people who have side effects when taking Temaz from the FDA, and is updated regularly.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

What is Pleurisy?

Pleurisy (inflammation of the pleurae, which causes pain when breathing) is found to be associated with 808 drugs and 1,141 conditions by eHealthMe. Check the latest studies of Pleurisy.

On Aug, 11, 2026

40,916 people reported to have side effects when taking Temaz.
Among them, 21 people (0.05%) have Pleurisy.

Among these 21 people:

What is the gender of people who have Pleurisy when taking Temaz? *

female: 76.19 %
male: 23.81 %

What is the age of people who have Pleurisy when taking Temaz? *

What are other drugs people take besides Temaz? *

What are other side effects people have besides Pleurisy? *

Chest Pain: 7 people, 33.33%
Back Pain: 5 people, 23.81%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 5 people, 23.81%
Cough: 5 people, 23.81%
Dyspnea (difficult or laboured breathing): 5 people, 23.81%
Increased Tendency To Bruise (increased tendency to injure the underlying soft tissue or bone): 5 people, 23.81%
Pain: 4 people, 19.05%
Nasopharyngitis (inflammation of the nasopharynx): 4 people, 19.05%
Pneumonia: 4 people, 19.05%
Pleural Effusion (water on the lungs): 4 people, 19.05%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 9.52%
Premenstrual Syndrome: 2 people, 9.52%
Blood Potassium Decreased: 2 people, 9.52%
Depression: 2 people, 9.52%
Hormone Level Abnormal: 2 people, 9.52%
Nasopharyngitis (inflammation of the nasopharynx): 2 people, 9.52%
Acne (skin problems that cause pimples): 2 people, 9.52%
Progressive Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord): 2 people, 9.52%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 9.52%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Temaz and have Pleurisy?

- Check whether Pleurisy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Temaz:

Temaz (42,293 reports)

Pleurisy treatments and more:

Pleurisy (9,090 reports)

Browse all side effects of Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pleurisy:

Pleurisy (808 drugs)

Browse all the conditions that are associated with Pleurisy:

Pleurisy (1,141 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on temazepam (the active ingredients of Temaz) and Temaz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.